Assessment of neurogenic bowel symptoms with the bowel dysfunction score in children with spina bifida: a prospective case–control study

Aim To compare the quality of life (QoL) in children with spina bifida with a control group of their peers using a validated questionnaire, the Neurogenic Bowel Dysfunction Score (NBDS). Methods The NBDS questionnaire was prospectively distributed to children attending a multi-disciplinary Spina Bif...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric surgery international 2020-07, Vol.36 (7), p.773-777
Main Authors: Gibbons, C., Coyle, D., White, C., Aldridge, E., Doyle, M., Cascio, S.
Format: Article
Language:English
Subjects:
Age
Bladder
Children & youth
Clinics
Constipation
Fecal incontinence
Hospitals
Laxatives
Medicine
Medicine & Public Health
Original Article
Patients
Pediatric Surgery
Pediatrics
Quality of life
Questionnaires
Spina bifida
Studies
Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim To compare the quality of life (QoL) in children with spina bifida with a control group of their peers using a validated questionnaire, the Neurogenic Bowel Dysfunction Score (NBDS). Methods The NBDS questionnaire was prospectively distributed to children attending a multi-disciplinary Spina Bifida clinic and healthy controls attending pediatric urology clinics. A score (out of 41) was assigned to each child based on their responses to the validated questionnaire. A lower score indicates better bowel function-related quality of life. SPSS software (v.25) was used for all statistical analysis. Results There were 98 respondents to the questionnaire, 48 children with spina bifida and 50 controls. The average age of respondents was 7.88 years (3–16 years). Of those with Spina Bifida, 33 (69%) were on retrograde rectal irrigations, [19 (58%) Peristeen® system, 11 (33%) tube rectal irrigations, and 3 (9%) Willis system], 6 (12%) were on laxatives, and 9 (19%) were on no treatment. The median NBDS for Spina Bifida patients was significantly higher 13.5 (2–32) compared to the control group 2 (0–26, p  
ISSN:0179-0358
1437-9813
DOI:10.1007/s00383-020-04670-8